Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatović, Laura Cook, Ashish Marwaha et al.|Nature Medicine|2024Cited by 40
Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 DiabetesYF Liu, Timothy Tree, Nikolaos Fountoulakis et al.|Diabetes|2022Cited by 22
Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 DiabetesYF Liu, Timothy Tree, Jake Powrie et al.|Unknown|2022Cited by 1
Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 DiabetesYF Liu, Timothy Tree, Jake Powrie et al.|Unknown|2022Cited by 0